{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T19:05:16Z","timestamp":1788635116557,"version":"build-2803163510"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.steroids.2024.109455","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T13:12:25Z","timestamp":1718284345000},"page":"109455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Polycystic ovary syndrome: Insights into its prevalence, diagnosis, and management with special reference to gut microbial dysbiosis"],"prefix":"10.1016","volume":"208","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3861-8372","authenticated-orcid":false,"given":"Nisha H.","family":"Khobragade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5815-4529","authenticated-orcid":false,"given":"Devang B.","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayesh V.","family":"Beladiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mittal","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.steroids.2024.109455_b0005","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","article-title":"The prevalence of polycystic ovary syndrome: A brief systematic review","volume":"13","author":"Deswal","year":"2020","journal-title":"J. Hum. Reprod. Sci."},{"key":"10.1016\/j.steroids.2024.109455_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2021.100123","article-title":"PCOS and nutritional approaches: Differences between lean and obese phenotype","volume":"12","author":"Barrea","year":"2021","journal-title":"Metabol Open."},{"issue":"5","key":"10.1016\/j.steroids.2024.109455_b0015","doi-asserted-by":"crossref","first-page":"493.e1","DOI":"10.1016\/j.ajog.2017.01.003","article-title":"Racial and ethnic differences in the polycystic ovary syndrome metabolic phenotype","volume":"216","author":"Engmann","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.steroids.2024.109455_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2024.108562","article-title":"Endocrine-disrupting chemicals and hormonal profiles in PCOS women: A comparative study between urban and rural environment","volume":"125","author":"Patel","year":"2024","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.steroids.2024.109455_b0025","doi-asserted-by":"crossref","DOI":"10.1007\/s43032-024-01548-1","article-title":"Exposure to PCOS: Findings from a Case-Control Investigation","author":"Patel","year":"2024","journal-title":"Reprod. Sci. [Internet]"},{"issue":"1","key":"10.1016\/j.steroids.2024.109455_b0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.fertnstert.2016.05.009","article-title":"Introduction: determinants of polycystic ovary syndrome","volume":"106","author":"Azziz","year":"2016","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.steroids.2024.109455_b0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/17446651.2017.1266250","article-title":"The role of stress in PCOS","volume":"12","author":"Papalou","year":"2017","journal-title":"Expert. Rev. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.steroids.2024.109455_b0040","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa177","article-title":"Intersection of polycystic ovary syndrome and the gut microbiome","volume":"5","author":"Rizk","year":"2021","journal-title":"J. Endocr. Soc."},{"issue":"1","key":"10.1016\/j.steroids.2024.109455_b0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/14656566.2022.2108702","article-title":"Current and emerging drug treatment strategies for polycystic ovary syndrome","volume":"24","author":"Helvaci","year":"2023","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.steroids.2024.109455_b0050","article-title":"Factors associated with ovarian hyperstimulation syndrome (OHSS) severity in women with polycystic ovary syndrome undergoing IVF\/ICSI","volume":"11","author":"Sun","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"11","key":"10.1016\/j.steroids.2024.109455_b0055","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s10815-022-02625-7","article-title":"A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS)","volume":"39","author":"Siddiqui","year":"2022","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.steroids.2024.109455_b0060","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2147\/IJWH.S165794","article-title":"Measures of health-related quality of life in PCOS women: a systematic review","author":"Behboodi Moghadam","year":"2018","journal-title":"Internat. J. Women\u2019s Health."},{"issue":"1","key":"10.1016\/j.steroids.2024.109455_b0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/metabo13010129","article-title":"The Implication of mechanistic approaches and the role of the microbiome in polycystic ovary syndrome (PCOS): A review","volume":"13","author":"Mukherjee","year":"2023","journal-title":"Metabolites"},{"issue":"3","key":"10.1016\/j.steroids.2024.109455_b0070","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00404-020-05951-2","article-title":"Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update","volume":"303","author":"Abraham Gnanadass","year":"2021","journal-title":"Arch. Gynecol. Obstet."},{"issue":"7","key":"10.1016\/j.steroids.2024.109455_b0075","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.3390\/biomedicines10071505","article-title":"Reconsidering the polycystic ovary syndrome (PCOS)","volume":"10","author":"Gleicher","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.steroids.2024.109455_b0080","doi-asserted-by":"crossref","first-page":"2085961","DOI":"10.1080\/19490976.2022.2085961","article-title":"The interplay between PCOS pathology and diet on gut microbiota in a mouse model","volume":"14","author":"Rodriguez Paris","year":"2022","journal-title":"Gut Microbes"},{"key":"10.1016\/j.steroids.2024.109455_b0085","first-page":"1","article-title":"Molecular mechanisms in the etiology of polycystic ovary syndrome (PCOS): A multifaceted hypothesis towards the disease with potential therapeutics","author":"Nisa","year":"2023","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.steroids.2024.109455_b0090","doi-asserted-by":"crossref","first-page":"1024320","DOI":"10.3389\/fendo.2022.1024320","article-title":"Posttranslational modifications in pathogenesis of PCOS","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.steroids.2024.109455_b0095","article-title":"Physiology of GNRH and gonadotropin secretion","author":"Marques","year":"2022","journal-title":"Endotext [Internet]."},{"issue":"11","key":"10.1016\/j.steroids.2024.109455_b0100","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1042\/CS20220146","article-title":"Assessing hypothalamic pituitary gonadal function in reproductive disorders","volume":"137","author":"Koysombat","year":"2023","journal-title":"Clin. Sci."},{"issue":"37","key":"10.1016\/j.steroids.2024.109455_b0105","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bpobgyn.2016.03.005","article-title":"Hypothalamic\u2013pituitary, ovarian and adrenal contributions to polycystic ovary syndrome","volume":"1","author":"Baskind","year":"2016","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"4","key":"10.1016\/j.steroids.2024.109455_b0110","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnaa010","article-title":"Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome","volume":"41","author":"Stener-Victorin","year":"2020","journal-title":"Endocr. Rev."},{"issue":"9","key":"10.1016\/j.steroids.2024.109455_b0115","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.3390\/nu15092230","article-title":"Effect of high fat diet on disease development of polycystic ovary syndrome and lifestyle intervention strategies","volume":"15","author":"Han","year":"2023","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.steroids.2024.109455_b0120","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr. Rev."},{"issue":"9","key":"10.1016\/j.steroids.2024.109455_b0125","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.3390\/diagnostics12092045","article-title":"Differentiating polycystic ovary syndrome from adrenal disorders","volume":"12","author":"Yesiladali","year":"2022","journal-title":"Diagnostics."},{"issue":"12","key":"10.1016\/j.steroids.2024.109455_b0130","article-title":"Central regulation of PCOS: abnormal neuronal-reproductive-metabolic circuits in PCOS pathophysiology","volume":"28","author":"Liao","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.steroids.2024.109455_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.01.001","article-title":"Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies","volume":"35","author":"Sanchez-Garrido","year":"2020","journal-title":"Molecular Metabolism."},{"issue":"1","key":"10.1016\/j.steroids.2024.109455_b0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.fertnstert.2011.11.036","article-title":"Should all women with PCOS be treated for insulin resistance?","volume":"97","author":"Marshall","year":"2012","journal-title":"Fertil. Steril."},{"issue":"10","key":"10.1016\/j.steroids.2024.109455_b0145","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqab118","article-title":"Intestinal flora is a key factor in insulin resistance and contributes to the development of polycystic ovary syndrome","volume":"162","author":"Yang","year":"2021","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.steroids.2024.109455_b0150","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3390\/jcm10040829","article-title":"Risk of insulin resistance and metabolic syndrome in women with hyperandrogenemia: A comparison between PCOS phenotypes and beyond","volume":"10","author":"Borzan","year":"2021","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.steroids.2024.109455_b0155","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.3390\/ijms24043140","article-title":"Insulin metabolism in polycystic ovary syndrome: secretion, signaling, and clearance","volume":"24","author":"Herman","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.steroids.2024.109455_b0160","unstructured":"Investigating the interplay between AMH gene polymorphism rs10407022 and clinical indicators in polycystic ovary syndrome - ScienceDirect [Internet]. [cited 2024 Jun 9]. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S2773044124000238?via%3Dihub."},{"issue":"1","key":"10.1016\/j.steroids.2024.109455_b0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s43042-019-0031-4","article-title":"Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: a review","volume":"20","author":"Ashraf","year":"2019","journal-title":"Egypt J Med Hum Genet."},{"issue":"6","key":"10.1016\/j.steroids.2024.109455_b0170","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1210\/endrev\/bnac001","article-title":"Deconstructing a syndrome: genomic insights into PCOS causal mechanisms and classification","volume":"43","author":"Dapas","year":"2022","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.steroids.2024.109455_b0175","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s43042-022-00263-3","article-title":"Association of FTO gene variants rs9939609 and rs1421085 with polycystic ovary syndrome","volume":"23","author":"Alnafjan","year":"2022","journal-title":"Egypt. J. Med. Human Genet."},{"key":"10.1016\/j.steroids.2024.109455_b0180","article-title":"Fat mass and Obesity Associated (FTO) gene and polycystic ovary syndrome: Insight into pathogenesis and association with insulin resistance","volume":"30","author":"Parveen","year":"2022","journal-title":"Human Nutrit. Metab."},{"issue":"1","key":"10.1016\/j.steroids.2024.109455_b0185","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12902-022-01206-0","article-title":"Evaluation of socio-demographic and clinical characteristics of PCOS patients attending a tertiary care institute in Colombo","volume":"22","author":"Ranathunga","year":"2022","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.steroids.2024.109455_b0190","doi-asserted-by":"crossref","unstructured":"Goh JE, Farrukh MJ, Keshavarzi F, Yap CS, Saleem Z, Salman M, et al. Assessment of prevalence, knowledge of polycystic ovary syndrome and health-related practices among women in klang valley: A cross-sectional survey. Front Endocrinol [Internet]. 2022 Aug 29 [cited 2024 Jun 9];13. Available from: https:\/\/www.frontiersin.org\/journals\/endocrinology\/articles\/10.3389\/fendo.2022.985588\/full.","DOI":"10.3389\/fendo.2022.985588"},{"issue":"1","key":"10.1016\/j.steroids.2024.109455_b0195","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12920-023-01654-0","article-title":"Association of FTO gene variant rs9939609 with polycystic ovary syndrome from Gujarat, India","volume":"16","author":"Chaudhary","year":"2023","journal-title":"BMC Med. Genomics"},{"issue":"6","key":"10.1016\/j.steroids.2024.109455_b0200","doi-asserted-by":"crossref","DOI":"10.22317\/jcms.v8i6.1298","article-title":"Molecular studies of CAPN-10 Gene (rs2975760) and its association with insulin resistance in polycystic ovarian syndrome of Iraqi women","volume":"8","author":"Al-Murshedi","year":"2022","journal-title":"J. Contemp. Med. Sci."},{"issue":"2","key":"10.1016\/j.steroids.2024.109455_b0205","first-page":"2294","article-title":"Relationship of polymorphisms of the AR Gene (Rs6152) with polycystic ovary syndrome in a group of Iraqi women","volume":"22","author":"Al-Tikriti","year":"2022","journal-title":"HIV Nursing."},{"issue":"3","key":"10.1016\/j.steroids.2024.109455_b0210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.25259\/JRHM_16_2021","article-title":"Role of genetic, environmental, and hormonal factors in the progression of PCOS: A review","volume":"28","author":"Kumar","year":"2022","journal-title":"JRHM."},{"key":"10.1016\/j.steroids.2024.109455_b0215","article-title":"Polycystic ovary syndrome (PCOS) and genetic predisposition: A review article","volume":"3","author":"Ajmal","year":"2019","journal-title":"Eur. J. Obst. Gynecol. Reproduct. Biol.: X."},{"issue":"6","key":"10.1016\/j.steroids.2024.109455_b0220","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/humupd\/dmw027","article-title":"Interactions between androgens, FSH, anti-M\u00fcllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary","volume":"22","author":"Dewailly","year":"2016","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.steroids.2024.109455_b0225","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fendo.2019.00023","article-title":"Follicle stimulating hormone receptor (FSHR) polymorphisms and polycystic ovary syndrome (PCOS)","volume":"10","author":"Laven","year":"2019","journal-title":"Front. Endocrinol."},{"issue":"14","key":"10.1016\/j.steroids.2024.109455_b0230","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13048-021-00879-w","article-title":"The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis","volume":"26","author":"Chaudhary","year":"2021","journal-title":"J Ovarian Res."},{"issue":"12","key":"10.1016\/j.steroids.2024.109455_b0235","doi-asserted-by":"crossref","first-page":"R305","DOI":"10.1530\/EC-21-0327","article-title":"CYP17 T\/C (rs74357) gene polymorphism contributes to polycystic ovary syndrome susceptibility: evidence from a meta-analysis","volume":"10","author":"Liu","year":"2021","journal-title":"Endocr. Connect."},{"issue":"5","key":"10.1016\/j.steroids.2024.109455_b0240","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3390\/metabo13050646","article-title":"Correlation between selected clinical symptoms and severity of aggression, impulsiveness and their selected behavioral manifestations in patients with polycystic ovary syndrome phenotype A","volume":"13","author":"Barabasz-Gembczyk","year":"2023","journal-title":"Metabolites"},{"issue":"12","key":"10.1016\/j.steroids.2024.109455_b0245","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.3390\/life12121974","article-title":"Polycystic ovary syndrome: An updated overview foregrounding impacts of ethnicities and geographic variations","volume":"12","author":"Yasmin","year":"2022","journal-title":"Life."},{"issue":"6","key":"10.1016\/j.steroids.2024.109455_b0250","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3390\/diagnostics13061113","article-title":"Current guidelines for diagnosing PCOS","volume":"13","author":"Christ","year":"2023","journal-title":"Diagnostics (basel)."},{"issue":"3","key":"10.1016\/j.steroids.2024.109455_b0255","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3390\/jcm12031221","article-title":"PCOS in adolescents\u2014ongoing riddles in diagnosis and treatment","volume":"12","author":"Meczekalski","year":"2023","journal-title":"JCM."},{"issue":"2","key":"10.1016\/j.steroids.2024.109455_b0260","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/14737159.2023.2177536","article-title":"Updates in diagnosing polycystic ovary syndrome-related infertility","volume":"23","author":"Haddad-Filho","year":"2023","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"3","key":"10.1016\/j.steroids.2024.109455_b0265","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4103\/JOD.JOD_105_20","article-title":"Prevalence of polycystic ovarian syndrome among adolescents and young women in India","volume":"12","author":"Mehreen","year":"2021","journal-title":"Journal of Diabetology."},{"issue":"6","key":"10.1016\/j.steroids.2024.109455_b0270","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1530\/EJE-09-1012","article-title":"High prevalence of polycystic ovary syndrome characteristics in girls with euthyroid chronic lymphocytic thyroiditis: a case\u2013control study","volume":"162","author":"Ganie","year":"2010","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.steroids.2024.109455_b0275","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jpag.2011.03.002","article-title":"Prevalence of polycystic ovarian syndrome in Indian adolescents","volume":"24","author":"Nidhi","year":"2011","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"issue":"Suppl 2","key":"10.1016\/j.steroids.2024.109455_b0280","first-page":"S389","article-title":"Prevalence of polycystic ovary syndrome in young women from North India: A Community-based study","volume":"16","author":"Gill","year":"2012","journal-title":"Indian J. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.steroids.2024.109455_b0285","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4103\/2230-8210.131162","article-title":"A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai","volume":"18","author":"Joshi","year":"2014","journal-title":"India. Indian J Endocrinol Metab."},{"issue":"1","key":"10.1016\/j.steroids.2024.109455_b0290","doi-asserted-by":"crossref","first-page":"95","DOI":"10.18203\/2394-6040.ijcmph20175603","article-title":"A cross sectional study of polycystic ovarian syndrome among young women in Bhopal, Central India","volume":"5","author":"Gupta","year":"2018","journal-title":"Internat. J. Commun. Med. Public Health."},{"issue":"2","key":"10.1016\/j.steroids.2024.109455_b0295","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4103\/0976-9668.184704","article-title":"Study on the proportion and determinants of polycystic ovarian syndrome among health sciences students in South India","volume":"7","author":"Joseph","year":"2016","journal-title":"J. Nat. Sci. Biol. Med."},{"issue":"2","key":"10.1016\/j.steroids.2024.109455_b0300","first-page":"17","article-title":"Polycystic ovarian syndrome: current situation of female hormonal disorder","volume":"19","author":"Chaturvedi","year":"2023","journal-title":"Curr. Women\u2019s Health Rev."},{"issue":"11","key":"10.1016\/j.steroids.2024.109455_b0305","first-page":"1039","article-title":"Veritable evaluation and inspection of PCOS and its apropos medicaments","volume":"59","author":"Priyadarshani","year":"2022","journal-title":"Indian J. Biochem. Biophys. (IJBB)."},{"issue":"2","key":"10.1016\/j.steroids.2024.109455_b0310","doi-asserted-by":"crossref","first-page":"e13580","DOI":"10.1111\/aji.13580","article-title":"Interplay between PCOS and microbiome: The road less travelled","volume":"88","author":"Batra","year":"2022","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.steroids.2024.109455_b0315","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.606751","article-title":"Microbiota as drivers and as therapeutic targets in ocular and tissue specific autoimmunity","volume":"8","author":"Salvador","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.steroids.2024.109455_b0320","doi-asserted-by":"crossref","first-page":"e0146509","DOI":"10.1371\/journal.pone.0146509","article-title":"The gut microbiome is altered in a letrozole-induced mouse model of polycystic ovary syndrome","volume":"11","author":"Kelley","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.steroids.2024.109455_b0325","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fnut.2019.00047","article-title":"The effects of vegetarian and vegan diets on gut microbiota","volume":"17","author":"Tomova","year":"2019","journal-title":"Front. Nutr."},{"issue":"13","key":"10.1016\/j.steroids.2024.109455_b0330","article-title":"Present and future: crosstalks between polycystic ovary syndrome and gut metabolites relating to gut microbiota","volume":"19","author":"Zhang","year":"2022","journal-title":"Front Endocrinol (lausanne)."},{"issue":"1","key":"10.1016\/j.steroids.2024.109455_b0335","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mehy.2012.04.016","article-title":"Dysbiosis of gut microbiota (DOGMA) \u2013 A novel theory for the development of Polycystic Ovarian Syndrome","volume":"79","author":"Tremellen","year":"2012","journal-title":"Med. Hypotheses"},{"issue":"1","key":"10.1016\/j.steroids.2024.109455_b0340","doi-asserted-by":"crossref","first-page":"e0146509","DOI":"10.1371\/journal.pone.0146509","article-title":"The gut microbiome is altered in a letrozole-induced mouse model of polycystic ovary syndrome","volume":"11","author":"Kelley","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.steroids.2024.109455_b0345","doi-asserted-by":"crossref","first-page":"e0168390","DOI":"10.1371\/journal.pone.0168390","article-title":"Alterations in gut microbiome composition and barrier function are associated with reproductive and metabolic defects in women with polycystic ovary syndrome (PCOS): A pilot study","volume":"12","author":"Lindheim","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.steroids.2024.109455_b0350","doi-asserted-by":"crossref","first-page":"11967","DOI":"10.1038\/s41598-023-39168-5","article-title":"Assessment of gut microbial \u03b2-glucuronidase and \u03b2-glucosidase activity in women with polycystic ovary syndrome","volume":"13","author":"Patel","year":"2023","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.steroids.2024.109455_b0355","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41591-019-0509-0","article-title":"Gut microbiota\u2013bile acid\u2013interleukin-22 axis orchestrates polycystic ovary syndrome","volume":"25","author":"Qi","year":"2019","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.steroids.2024.109455_b0360","doi-asserted-by":"crossref","first-page":"e0153196","DOI":"10.1371\/journal.pone.0153196","article-title":"Association between Polycystic Ovary Syndrome and Gut Microbiota","volume":"11","author":"Guo","year":"2016","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.steroids.2024.109455_b0365","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.tem.2018.11.001","article-title":"Sex, microbes, and polycystic ovary syndrome","volume":"30","author":"Thackray","year":"2019","journal-title":"Trends Endocrinol Metab"},{"issue":"88","key":"10.1016\/j.steroids.2024.109455_b0370","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.yhbeh.2016.10.016","article-title":"Sex steroids mediate bidirectional interactions between hosts and microbes","volume":"1","author":"vom Steeg","year":"2017","journal-title":"Horm. Behav."},{"issue":"5","key":"10.1016\/j.steroids.2024.109455_b0375","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.patbio.2007.09.008","article-title":"Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding","volume":"56","author":"Cani","year":"2008","journal-title":"Pathol. Biol."},{"issue":"7122","key":"10.1016\/j.steroids.2024.109455_b0380","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.steroids.2024.109455_b0385","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/ph16020197","article-title":"Interplay of gut microbiota in polycystic ovarian syndrome: role of gut microbiota, mechanistic pathways and potential treatment strategies","volume":"16","author":"Corrie","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.steroids.2024.109455_b0390","first-page":"89","article-title":"PPM1K-regulated impaired catabolism of branched-chain amino acids orchestrates polycystic ovary syndrome","author":"Mu","year":"2023","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.steroids.2024.109455_b0395","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/oby.23380","article-title":"Constant light exposure alters gut microbiota and short-\/medium-chain fatty acids and aggravates PCOS-like traits in HFD-fed rats","volume":"30","author":"Yue","year":"2022","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.steroids.2024.109455_b0400","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3389\/fphar.2020.00554","article-title":"Like cures like: pharmacological activity of anti-inflammatory lipopolysaccharides from gut microbiome","volume":"11","author":"Lin","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.steroids.2024.109455_b0405","article-title":"Effects of Bu Shen Hua Zhuo formula on the LPS\/TLR4 pathway and gut microbiota in rats with letrozole-induced polycystic ovary syndrome","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol (lausanne)."},{"issue":"1","key":"10.1016\/j.steroids.2024.109455_b0410","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5468\/ogs.21185","article-title":"A narrative review of the role of gastrointestinal dysbiosis in the pathogenesis of polycystic ovary syndrome","volume":"65","author":"Parker","year":"2022","journal-title":"Obstet. Gynecol. Sci."},{"issue":"1","key":"10.1016\/j.steroids.2024.109455_b0415","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12902-019-0486-9","article-title":"PCOS without hyperandrogenism is associated with higher plasma Trimethylamine N-oxide levels","volume":"20","author":"Huang","year":"2020","journal-title":"BMC Endocr. Disord."},{"issue":"2","key":"10.1016\/j.steroids.2024.109455_b0420","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/a-1081-2036","article-title":"Exploration of the relationship between gut microbiota and polycystic ovary syndrome (PCOS): a review","volume":"80","author":"Zhao","year":"2020","journal-title":"Geburtshilfe Frauenheilkd."},{"issue":"2","key":"10.1016\/j.steroids.2024.109455_b0425","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.livres.2020.05.001","article-title":"Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis","volume":"4","author":"Chiang","year":"2020","journal-title":"Liver Research."},{"issue":"2","key":"10.1016\/j.steroids.2024.109455_b0430","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3390\/nu14020279","article-title":"Yogurt enriched with inulin ameliorated reproductive functions and regulated gut microbiota in dehydroepiandrosterone-induced polycystic ovary syndrome mice","volume":"14","author":"Li","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.steroids.2024.109455_b0435","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5468\/ogs.21185","article-title":"A narrative review of the role of gastrointestinal dysbiosis in the pathogenesis of polycystic ovary syndrome","volume":"65","author":"Parker","year":"2022","journal-title":"Obstet. Gynecol. Sci."},{"key":"10.1016\/j.steroids.2024.109455_b0440","doi-asserted-by":"crossref","DOI":"10.1177\/11786469221099214","article-title":"The Kynurenine pathway and polycystic ovary syndrome: inflammation as a common denominator","volume":"15","author":"Jovanovic","year":"2022","journal-title":"Internat. J. Tryptophan Res."},{"key":"10.1016\/j.steroids.2024.109455_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105951","article-title":"Key role of the gut\u2013microbiota\u2013brain axis via the subdiaphragmatic vagus nerve in demyelination of the cuprizone-treated mouse brain","volume":"176","author":"Wang","year":"2023","journal-title":"Neurobiol. Dis."},{"issue":"13","key":"10.1016\/j.steroids.2024.109455_b0450","doi-asserted-by":"crossref","first-page":"1015175","DOI":"10.3389\/fneur.2022.1015175","article-title":"Recognizing the role of the vagus nerve in depression from microbiota-gut brain axis","volume":"10","author":"Tan","year":"2022","journal-title":"Front. Neurol."},{"issue":"5","key":"10.1016\/j.steroids.2024.109455_b0455","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.bbadis.2016.05.025","article-title":"Western-style diet, sex steroids and metabolism","volume":"1863","author":"Varlamov","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"8","key":"10.1016\/j.steroids.2024.109455_b0460","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.3390\/ijms23084110","article-title":"Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism","volume":"23","author":"Armanini","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.steroids.2024.109455_b0465","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/13543784.2020.1781815","article-title":"Current and experimental drug therapy for the treatment of polycystic ovarian syndrome","volume":"29","author":"Della Corte","year":"2020","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"9","key":"10.1016\/j.steroids.2024.109455_b0470","doi-asserted-by":"crossref","first-page":"1060581","DOI":"10.3389\/fmed.2022.1060581","article-title":"Fecal microbiota transplantation in non-communicable diseases: Recent advances and protocols","volume":"8","author":"Hamamah","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.steroids.2024.109455_b0475","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.3389\/fimmu.2019.02653","article-title":"Fecal microbiota transplantation: A potential tool for treatment of human female reproductive tract diseases","volume":"10","author":"Quaranta","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.steroids.2024.109455_b0480","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.csbj.2022.03.017","article-title":"Microorganisms in the reproductive system and probiotic\u2019s regulatory effects on reproductive health","volume":"20","author":"Feng","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"2022","key":"10.1016\/j.steroids.2024.109455_b0485","first-page":"1","article-title":"Impact of Chinese herbal medicine on glucolipid metabolic outcomes in women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"30","author":"Li","year":"2022","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"4","key":"10.1016\/j.steroids.2024.109455_b0490","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1159\/000518040","article-title":"Berberine improves the symptoms of DHEA-induced PCOS rats by regulating gut microbiotas and metabolites","volume":"86","author":"Shen","year":"2021","journal-title":"Gynecol. Obstet. Invest."},{"issue":"3","key":"10.1016\/j.steroids.2024.109455_b0495","doi-asserted-by":"crossref","first-page":"e13644","DOI":"10.1111\/aji.13644","article-title":"Quercetin and polycystic ovary syndrome; inflammation, hormonal parameters and pregnancy outcome: A randomized clinical trial","volume":"89","author":"Vaez","year":"2023","journal-title":"Am. J. Reprod. Immunol."},{"issue":"1","key":"10.1016\/j.steroids.2024.109455_b0500","doi-asserted-by":"crossref","first-page":"22184","DOI":"10.1038\/s41598-022-25041-4","article-title":"Gut microbiome in PCOS associates to serum metabolomics: a cross-sectional study","volume":"12","author":"Yu","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.steroids.2024.109455_b0505","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1186\/s12906-017-2011-x","article-title":"Nutritional supplements and herbal medicines for women with polycystic ovary syndrome; a systematic review and meta-analysis","volume":"17","author":"Arentz","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"issue":"7","key":"10.1016\/j.steroids.2024.109455_b0510","doi-asserted-by":"crossref","first-page":"e1009774","DOI":"10.1371\/journal.ppat.1009774","article-title":"Aryl hydrocarbon receptor activation by Lactobacillus reuteri tryptophan metabolism alleviates Escherichia coli-induced mastitis in mice","volume":"17","author":"Zhao","year":"2021","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.steroids.2024.109455_b0515","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211031758","article-title":"Effects of probiotic and synbiotic supplementation on insulin resistance in women with polycystic ovary syndrome: a meta-analysis","volume":"49","author":"Miao","year":"2021","journal-title":"J. Int. Med. Res."},{"issue":"14","key":"10.1016\/j.steroids.2024.109455_b0520","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.3390\/nu15143144","article-title":"Probiotics and polycystic ovary syndrome: A perspective for management in adolescents with obesity","volume":"15","author":"Calcaterra","year":"2023","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.steroids.2024.109455_b0525","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s40618-022-01943-y","article-title":"Short-time effects of ketogenic diet or modestly hypocaloric Mediterranean diet on overweight and obese women with polycystic ovary syndrome","volume":"46","author":"Cincione","year":"2023","journal-title":"J. Endocrinol. Invest."},{"issue":"12","key":"10.1016\/j.steroids.2024.109455_b0530","doi-asserted-by":"crossref","first-page":"e0260765","DOI":"10.1371\/journal.pone.0260765","article-title":"Polydextrose with and without Bifidobacterium animalis ssp. lactis 420 drives the prevalence of Akkermansia and improves liver health in a multi-compartmental obesogenic mice study","volume":"16","author":"Yde","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1016\/j.steroids.2024.109455_b0535","article-title":"Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications","volume":"13","author":"Sun","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.steroids.2024.109455_b0540","doi-asserted-by":"crossref","first-page":"1141355","DOI":"10.3389\/fmed.2023.1141355","article-title":"The effects of probiotics, prebiotics, and synbiotics on polycystic ovarian syndrome: an overview of systematic reviews","volume":"10","author":"Angoorani","year":"2023","journal-title":"Front. Med."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X2400093X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X2400093X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T03:05:18Z","timestamp":1719975918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X2400093X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":108,"alternative-id":["S0039128X2400093X"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2024.109455","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polycystic ovary syndrome: Insights into its prevalence, diagnosis, and management with special reference to gut microbial dysbiosis","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2024.109455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109455"}}